Gary Zieziula
Director/Board Member at INNOVENT BIOLOGICS, INC.
Net worth: 23 851 $ as of 29/04/2024
Gary Zieziula active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INNOVENT BIOLOGICS, INC. | Director/Board Member | 30/05/2022 | - |
| Independent Dir/Board Member | 30/05/2022 | - |
Career history of Gary Zieziula
Former positions of Gary Zieziula
| Companies | Position | Start | End |
|---|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 31/12/2013 | - |
| President | - | 31/08/2018 | |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 27/04/2010 | 03/11/2011 |
| MERCK & CO., INC. | Sales & Marketing | - | - |
| BRISTOL-MYERS SQUIBB COMPANY | Sales & Marketing | - | - |
Training of Gary Zieziula
| Canisius College | Masters Business Admin |
| State University of New York at Buffalo | Undergraduate Degree |
Statistics
International
| United States | 7 |
| Cayman Islands | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Sales & Marketing | 2 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| INNOVENT BIOLOGICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Stock Market
- Insiders
- Gary Zieziula
- Experience
